OTCMKTS:HLUYY

H. Lundbeck A/S Stock Forecast, Price & News

$30.67

-0.43 (-1.37 %)

(As of 06/17/2021 03:22 PM ET)

Add

Compare

Today's Range

$30.43

▼

$30.78

50-Day Range

$30.06

▼

$35.88

52-Week Range

$27.92

▼

$43.05

Volume1,868 shs

Average Volume2,883 shs

Market Capitalization$6.11 billion

P/E Ratio17.43

Dividend Yield0.87%

Beta0.73

30 days | 90 days | 365 days | Advanced Chart

Receive HLUYY News and Ratings via Email

Sign-up to receive the latest news and ratings for H. Lundbeck A/S and its competitors with MarketBeat's FREE daily newsletter.

About H. Lundbeck A/S

H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Onfi for Lennox-Gastaut syndrome; Vyepti for migraine prevention; and Rexulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership agreement with Verantos to focus on a study to enable real-world evidence in support of migraine therapy. The company was founded in 1915 and is headquartered in Valby, Denmark.

H. Lundbeck A/S (OTCMKTS:HLUYY) Rating Reiterated by Barclays
June 16, 2021 | americanbankingnews.com

H. Lundbeck A/S (OTCMKTS:HLUYY) Given Average Rating of "Hold" by Analysts
June 13, 2021 | americanbankingnews.com

Harvard's Wyss Institute initiates industry partnership to facilitate brain-targeted drug delivery
June 10, 2021 | markets.businessinsider.com

Lundbeck to Showcase New VYEPTI® (eptinezumab-jjmr) Data at 63rd Annual Scientific Meeting of the American Headache Society (AHS)
June 3, 2021 | nz.finance.yahoo.com

H. Lundbeck A/S (OTCMKTS:HLUYY) Sees Large Decline in Short Interest
May 28, 2021 | americanbankingnews.com

H. Lundbeck A/S 2021 Q1 - Results - Earnings Call Presentation
May 11, 2021 | seekingalpha.com

Lundbeck beats first quarter sales expectations, keeps outlook
April 22, 2021 | finance.yahoo.com

Otsuka and Lundbeck Announce Decision to Continue Phase III Clinical Trial Evaluating Brexpiprazole for Treatment of Agitation in Patients With Alzheimer's-type Dementia
April 13, 2021 | businesswire.com

Depression Treatment Market Share Worth USD 16.06 Billion by 2027, Market trends – in Increase in depression among millennials
April 2, 2021 | marketwatch.com

H. Lundbeck A/S (HLUYY)
March 24, 2021 | au.finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:HLUYY
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.lundbeck.com
Phone45-3630-1311
Employees5,628
Year FoundedN/A

Sales & Book Value

Annual Sales$2.71 billion
Price / Sales2.26
Cash Flow$4.88 per share
Price / Cash Flow6.29
Book Value$13.06 per share
Price / Book2.35

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares199,148,000
Market Cap$6.11 billion
Next Earnings Date8/12/2021 (Estimated)
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

1.44 out of 5 stars

Medical Sector

680th out of 2,102 stocks

Private Households Industry

36th out of 381 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for H. Lundbeck A/S.

2.4 Community Rank

Outperform Votes
H. Lundbeck A/S has received 198 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
H. Lundbeck A/S has received 209 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
H. Lundbeck A/S has received 51.35% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about H. Lundbeck A/S and other stocks. Vote “Outperform” if you believe HLUYY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe HLUYY will underperform the S&P 500 over the long term. You may vote once every thirty days.

1.7 Dividend Strength

Dividend Yield
H. Lundbeck A/S has a dividend yield of 0.87%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
H. Lundbeck A/S does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of H. Lundbeck A/S is 9.31%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, H. Lundbeck A/S will have a dividend payout ratio of 12.27% next year. This indicates that H. Lundbeck A/S will be able to sustain or increase its dividend.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, H. Lundbeck A/S insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 0.08% of the stock of H. Lundbeck A/S is held by institutions.

3.1 Earnings and Valuation

Earnings Growth
Earnings for H. Lundbeck A/S are expected to grow by 18.92% in the coming year, from $1.85 to $2.20 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of H. Lundbeck A/S is 17.43, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 29.43.
Price to Earnings Ratio vs. Sector
The P/E ratio of H. Lundbeck A/S is 17.43, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 44.17.
Price to Book Value per Share Ratio
H. Lundbeck A/S has a P/B Ratio of 2.35. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

H. Lundbeck A/S (OTCMKTS:HLUYY) Frequently Asked Questions

Is H. Lundbeck A/S a buy right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for H. Lundbeck A/S in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" H. Lundbeck A/S stock.
View analyst ratings for H. Lundbeck A/S or view top-rated stocks.

What stocks does MarketBeat like better than H. Lundbeck A/S?

Wall Street analysts have given H. Lundbeck A/S a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but H. Lundbeck A/S wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting H. Lundbeck A/S?

H. Lundbeck A/S saw a drop in short interest in May. As of May 14th, there was short interest totaling 200 shares, a drop of 66.7% from the April 29th total of 600 shares. Based on an average daily trading volume, of 3,700 shares, the short-interest ratio is currently 0.1 days.
View H. Lundbeck A/S's Short Interest.

When is H. Lundbeck A/S's next earnings date?

H. Lundbeck A/S is scheduled to release its next quarterly earnings announcement on Thursday, August 12th 2021.
View our earnings forecast for H. Lundbeck A/S.

How were H. Lundbeck A/S's earnings last quarter?

H. Lundbeck A/S (OTCMKTS:HLUYY) posted its quarterly earnings data on Wednesday, November, 4th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.16. The firm had revenue of $547.05 million for the quarter, compared to the consensus estimate of $514.82 million. H. Lundbeck A/S had a net margin of 12.82% and a trailing twelve-month return on equity of 23.57%.
View H. Lundbeck A/S's earnings history.

How has H. Lundbeck A/S's stock price been impacted by Coronavirus (COVID-19)?

H. Lundbeck A/S's stock was trading at $31.52 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, HLUYY stock has decreased by 2.7% and is now trading at $30.67.
View which stocks have been most impacted by COVID-19.

How often does H. Lundbeck A/S pay dividends? What is the dividend yield for H. Lundbeck A/S?

H. Lundbeck A/S announced an annual dividend on Thursday, February 4th. Shareholders of record on Thursday, March 25th will be given a dividend of $0.275 per share on Friday, April 2nd. This represents a yield of 0.68%. The ex-dividend date is Wednesday, March 24th.
View H. Lundbeck A/S's dividend history.

Is H. Lundbeck A/S a good dividend stock?

H. Lundbeck A/S pays an annual dividend of $0.27 per share and currently has a dividend yield of 0.87%. The dividend payout ratio of H. Lundbeck A/S is 9.31%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, H. Lundbeck A/S will have a dividend payout ratio of 12.27% next year. This indicates that H. Lundbeck A/S will be able to sustain or increase its dividend.
View H. Lundbeck A/S's dividend history.

Who are H. Lundbeck A/S's key executives?

H. Lundbeck A/S's management team includes the following people:

Dr. Deborah Dunsire, Pres & CEO (Age 59, Pay $3.13M)
Mr. Anders GÃ¶tzsche, Exec. VP & CFO (Age 54, Pay $1.46M)
Mr. Lars Bang, Exec. VP of Product Devel. & Supply (Age 59, Pay $1.16M)
Mr. Jacob Tolstrup, Exec. VP of Commercial Operations (Age 49, Pay $1.11M)
Dr. Per Johan Luthman, Exec. VP of R&D (Age 62, Pay $1.1M)
Dr. Tarek Samad, Sr. VP & Head of Research
Mr. Palle Holm Olesen, Chief Specialist & VP of Investor Relations
Juliane Lenzner, VP of Corp. Communication
Ms. Elise Hauge, Exec. VP and Head of People & Communication (Age 54)
Mr. Ole Chrintz, Sr. VP of International Markets (Age 63)

Who are some of H. Lundbeck A/S's key competitors?

Some companies that are related to H. Lundbeck A/S include BAE Systems (BAESY), Unicharm (UNICY), SGS (SGSOY), China Mengniu Dairy (CIADY), Kerry Group (KRYAY), Deutsche Wohnen (DWHHF), Ferrovial (FRRVY), Sysmex (SSMXY), Wilmar International (WLMIY), Suzuki Motor (SZKMY), Chow Tai Fook Jewellery Group (CJEWY), Ocado Group (OCDDY), Sino Biopharmaceutical (SBMFF), Nomura Research Institute (NRILY) and Eurofins Scientific (ERFSF).
View all of HLUYY's competitors.

What is H. Lundbeck A/S's stock symbol?

H. Lundbeck A/S trades on the OTCMKTS under the ticker symbol "HLUYY."

How do I buy shares of H. Lundbeck A/S?

Shares of HLUYY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is H. Lundbeck A/S's stock price today?

One share of HLUYY stock can currently be purchased for approximately $30.67.

How much money does H. Lundbeck A/S make?

H. Lundbeck A/S has a market capitalization of $6.11 billion and generates $2.71 billion in revenue each year. The company earns $242.21 million in net income (profit) each year or $2.90 on an earnings per share basis.

How many employees does H. Lundbeck A/S have?

H. Lundbeck A/S employs 5,628 workers across the globe.

What is H. Lundbeck A/S's official website?

The official website for H. Lundbeck A/S is www.lundbeck.com.

Where are H. Lundbeck A/S's headquarters?

H. Lundbeck A/S is headquartered at Ottiliavej 9 Valby, Copenhagen G7, 2500.

How can I contact H. Lundbeck A/S?

H. Lundbeck A/S's mailing address is Ottiliavej 9 Valby, Copenhagen G7, 2500. The company can be reached via phone at 45-3630-1311 or via email at [email protected]

This page was last updated on 6/17/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here